3Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal resuits From the Women's Health Initiative randomized controlled trial. JAMA, 2002,288(3):321
4Ettinger B, Black DM, Mitlak BH et al. Reduction of vertebral fracture risk in post menopausal women with osteoporosis treated with raloxifene: results from a 3 - year randomized clinicaltrial, multiple outcomes of Raloxifene Evaluation Investigators. JAMA, 1999, 282:637
5Morgante G, Faring M, CianciA et al. Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early pearly postmenopausal women. Gynecol Endocrinol, 2004, 18 (4) : 194
6Quandt SA, Thompson DE, Schneider DL et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density Tscores of - 1.6 to - 2.5 at the femoral neck : the fracture intervention trial. Mayo Clinic Proceedings, 2005, 80 (3) : 343
7Chesnut CH3 rd, silverman S, Andriano K et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women established hosteoporosis: the prevent recurrence of osteoporotic fractured study. AmJ Med, 2000, 109 (4): 267
8Beverley S, George W, Ann C, Nicole Z et al. Meta - Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis. Endocrine Reviews, 2002, 23 (4): 552
9Sairanen S, Karkkainen M, Tahtela R et al. Bone mass and markers of bone and calcium metaboism in postmenopausal women treated with vitamin D for four years. Calcif Tissue Int, 2000, 67 (2) : 122
10Hagueuauer D, Welch V, Shea B, T et al. Fluoride for treating postmenopausal osteoporosis (Cochrane Review) [M/CD) . The Cocrane Library, Issue3, 2003
